Related Experiment Video
Updated: Mar 16, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
"Understanding the experiences and needs of patients with MDR/XDR-TB: A qualitative metasynthesis"
Mamta Choudhary1, Mamta2, Pushpa3
1College of Nursing, AIIMS, New Delhi, India.
Abstract:
Multidrug-resistant and extensively drug-resistant tuberculosis (MDR/XDR-TB) continues to present critical public health and individual challenges, especially in high-burden settings such as India. Despite advancements in diagnostics and therapeutics, individuals affected by MDR/XDR-TB often endure significant psychosocial, economic, and systemic hardships that are insufficiently addressed in the current literature. While most studies on this topic adopt quantitative methods, there remains a lack of synthesized qualitative evidence that captures the lived experiences and specific needs of these patients. This metasynthesis systematically reviewed and integrated findings from qualitative studies published between 2015 and June 2024, drawing on data from eleven studies conducted across eight countries and involving 259 participants. The analysis identified two major thematic domains namely experiences and needs. Patients reported pervasive emotional distress, social stigma, physical suffering from treatment side effects, economic strain, and psychological resilience. Their expressed needs included access to accurate information, compassionate and respectful healthcare relationships, psychosocial and financial support, and better management of treatment-related challenges. These findings reveal the deeply interwoven nature of psychosocial, medical, and structural barriers faced by individuals with MDR/XDR-TB. The study highlights the urgent need for holistic, person-centred interventions that address not only the clinical but also the emotional and socioeconomic dimensions of care, with the goal of improving patient well-being and treatment outcomes.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Therapeutic Drug Monitoring: Affecting Factors
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

